Compare ARK Genomic Revolution ETF (ARKG) vs BlackRock TCP Capital Corp (TCPC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs BlackRock TCP Capital Corp — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while BlackRock TCP Capital Corp trades at $3.26 (market cap $273.10M). The key difference: BlackRock TCP Capital Corp pays a 25.81% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, BlackRock TCP Capital Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | TCPC | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $7.90 |
52-Week Low | $23.09 | $3.14 |
Market Cap | — | $273.10M |
Dividend Yield | — | 25.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
TCPC trades at $3.26, up 3.16% today, but faces a bearish technical outlook with negative revenue and net income trends. The company reported a net loss of $88.93M for 2025 with revenue of -$77.27M, though it maintains a dividend yield above 10%. Recent news highlights potential dividend sustainability concerns and an ongoing legal investigation into corporate governance.
The outlook remains challenging with declining fundamentals and bearish technical signals. Investment opportunities exist for income-focused investors due to high dividend yield, but risks include persistent losses, legal scrutiny, and negative analyst sentiment with only 30.77% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About BlackRock TCP Capital Corp
BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →
